Supplemental Figure S8 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma | Synapse
August 1, 2024Open Access
Supplemental Figure S8 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Defining parameters for the evaluation of effects of DNA-PK inhibitors plus TOP2 poisons in preclinical models of EWS